RecruitingNCT03848052

Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC)

Studying PAPA syndrome

Last synced from ClinicalTrials.gov May 16, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: UNICANCER
Principal Investigator: Anne-Laure Martin, Pharmacist
UNICANCER
Enrollment: 70000 target
Eligibility: 18 years · All sexes
Timeline: 2017 – 2025

Study locations (21)

Institut de Cancérologie de l'Ouest - Paul Papin, Angers, France
Institut Bergonié, Bordeaux, France
Centre François Baclesse, Caen, France
Centre Jean Perrin, Clermont-Ferrand, France
Hôpital Intercommunal de Créteil, Créteil, France
Centre Georges-François Leclerc, Dijon, France
Centre Oscar Lambret, Lille, France
Centre Léon Bérard, Lyon, France
Institut Paoli-Calmettes, Marseille, France
Institut régional du Cancer Montpellier / Val d'Aurelle, Montpellier, France
Groupe Hospitalier Région Mulhouse et Sud Alsace - Hôpital Emile Muller, Mulhouse, France
Institut de cancérologie de l'Ouest - René Gauducheau, Nantes, France
Centre Antoine Lacassagne, Nice, France
Institut Curie, Paris, France
Institut Jean Godinot, Reims, France
+6 more locations on ClinicalTrials.gov

Collaborators

AstraZeneca · Merck Sharp & Dohme LLC · Roche Pharma AG · Pfizer · Bristol-Myers Squibb · Janssen, LP · Amgen · Daiichi Sankyo · Pierre Fabre Medicament · QUINTEN HEALTH

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03848052 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome →

← Back to all trials